March 8th, 2014

Evaluating the value of supportive medical apps during the treatment for breast cancer

Young-Afat et al, 2014; Amsterdam EBCC9.

May 4th, 2013

First place in the Digital Health Masterclass Challenge 2013

Px HealthCare won first place in the Digital Health Masterclass Challenge held by Janssen Healthcare Innovation and Johnson & Johnson Innovation.

March 1st, 2023

Home

Our mission is to revolutionise the use of the patient’s voice to improve both patient experience and clinical outcomes in cancer.

June 23rd, 2016

NHS Innovation Accelerator

Anne joined the NHS Innovation Accelerator (NIA) from the Netherlands … Continue reading “NHS Innovation Accelerator”

June 4th, 2016

Optimising oncology outcomes with a mobile app for breast cancer patients: A qualitative evaluation.

2016 NCRI Conference

December 10th, 2017

Is there value in using patient recorded outcome measures to improve toxicity management patients receiving chemotherapy for breast cancer?

2017 Annual British Oncology Pharmacy Association Symposium

December 7th, 2023

Extended: Px HealthCare Unveils First-of-its-Kind, Real World Evidence Study Using OWise Breast Cancer Patient Support App

Find here the extended notes associated with the RELATE-2 Study, Owise and Px Healthcare.

September 26th, 2024

Px HealthCare Presents Comparative Regional Evaluation of OWise Breast Cancer Patient Support App

Px HealthCare, the digital health company behind the clinically-validated OWise cancer patient support app, announced today the presentation of a first-of-its-kind Real World Evidence study at the San Antonio Breast Cancer Symposium 2023.

December 7th, 2023

Px HealthCare Unveils First-of-its-Kind, Real World Evidence Study Using OWise Breast Cancer Patient Support App

Px HealthCare, the digital health company behind the clinically-validated OWise cancer patient support app, announced today the presentation of a first-of-its-kind Real World Evidence study at the San Antonio Breast Cancer Symposium 2023.

February 4th, 2018

OWise receives top prize in Scotland’s Cancer Innovation Challenge

OWise was one of the projects selected to win the finals and progress to phase two of the Cancer Innovation Challenge!